Affiliation:
1. Privolzhsky Research Medical University
Abstract
Infection of burn wounds caused by antibiotic-resistant pathogens is the leading cause of systemic infectious complications in burned patients and a key link in the pathogenesis of burn disease, causing its course and outcome. The use of phage therapy to overcome antibiotic resistance of infection agents is a promising direction, the development of which can improve the results of treatment of burned. The article discusses: 1) features of the infectious process in burned; 2) the effect of antibacterial chemotherapy of burn wound infection on the microbiome and the processes of reparative regeneration; 3) principles of phage therapy; 4) ways of delivering bacteriophages; 5) development of resistance to bacteriophages 6) personalization of phage therapy.
Publisher
RPO Surgical Society - Wound and Wound Infections
Reference63 articles.
1. Vigani A., Culler C. A. Systemic and Local Management of Burn Wounds. Vet Clin North Am Small Anim Pract. 2017; 47 (6): 1149–1163.
2. Jeschke M. G., van Baar M. E., Choudhry M. A., et al. Burn injury. Nat Rev Dis Primers. 2020; 6 (1): 11.
3. Tsai S. Y., Lio C. F., Yao W. C., et al. Cost-drivers of medical expenses in burn care management. Burns. 2020; 46 (4): 817–824.
4. Stewart W. H. New challenges in public health in The United States of America. Bol Oficina Sanit Panam. 1967; 62 (1): 53–56.
5. Baquero F., Martínez J. L., F. Lanza V., et al. Evolutionary Pathways and Trajectories in Antibiotic Resistance. Clin Microbiol Rev. 2021; 34 (4): e0005019.